MeAgain is a health-tracking app for GLP-1 medication users, providing tools for dose logging, nutrition, and symptom monitoring on iOS and Android.
Product velocity
Maintenance
Daily rank 🇺🇸
#108
▲29Health & Fitness · free
Sentiment
4.8
30k reviews
Nemesis
Fragmented field
The App DNA
What makes this app unique?
Users hire MeAgain to manage the mental load of complex GLP-1 injection and pill routines, seeking a single source of truth for their health data.
For Individuals prescribed GLP-1 medications who need a centralized tool to manage medication schedules, nutrition, and side effects.
What does it look like?
Key features
Logs dose timing, injection sites, and pill routines for specific medications. Revenue link: Gates advanced medication context behind the subscription tier.
Tracks protein, fiber, and water intake alongside side-effect severity ratings. Revenue link: Core value proposition for the premium tier.
Home screen widget featuring a mascot to keep medication and nutrition routines visible. Revenue link: Retention loop to drive daily active usage.
How much does it cost?
Freemium model gates advanced tracking features behind a subscription, targeting users who require detailed health monitoring.
Velocity
Maintenance developmentUX improvementsperformanceShow more...
The app ships approximately 0.08 releases per week, placing it firmly in the maintenance tier. Development is currently focused on minor stability and tracking improvements rather than new feature expansion. The latest release from May 2026 provided general fixes for daily logging, but the significant gap in updates suggests a low-frequency maintenance cycle. There is no evidence of live-ops activity or rapid feature iteration.
Who built it?
User Sentiment
What do users think recently?
The recent review mood reads frustrated. Users appreciate the medication and nutrition tracking features provide a helpful structure for users on health journeys and responsive customer support teams resolve technical issues and refund requests for dissatisfied premium subscribers, but report frequent app crashes and ui freezing prevent users from logging daily health data consistently.
How are ratings & reviews evolving?
Weekly average review rating
What users say, by theme
- The medication and nutrition tracking features provide a helpful structure for users on health journeys
- Responsive customer support teams resolve technical issues and refund requests for dissatisfied premium subscribers
- Frequent app crashes and UI freezing prevent users from logging daily health data consistently
50 of 50 recent reviews analyzed · high confidence · Frustrated overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for MeAgain: GLP-1 Tracker App
How's the Health & Fitness market?
MeAgain occupies a niche in the Health & Fitness category, maintaining a 4.56-star rating across 30,039 total ratings. The lack of recent feature updates relative to the competitive landscape suggests a defensive posture rather than an aggressive growth strategy.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for MeAgain: GLP-1 Tracker App
Where is it heading?
The GLP-1 tracking market is consolidating, and MeAgain's current focus on maintenance rather than stability or feature growth leaves it exposed to churn. The PM must address the performance regressions immediately to prevent a permanent loss of the user base to more stable, generalist alternatives.
- Frequent crashes and UI lag in the latest update prevent consistent logging, which directly correlates with the recent decline in user sentiment.
- Aggressive paywalling of basic features creates a negative feedback loop that suppresses new user acquisition and drives negative reviews.
The SWOT
- Specialized GLP-1 data architecture centralizes injection, symptom, and nutrition logs
- Mascot-based widget creates a visual retention hook for daily medication adherence
- Expand B2B partnerships with GLP-1 providers to offer the app as a patient-support tool
- Integrate wearable health data to automate nutrition and movement logging
Next best moves
Audit paywall triggers because users report being forced to subscribe immediately after onboarding → increase free-tier conversion
+ 1 more prioritized moveThe counter-intuitive read
The app's current maintenance-mode status is a strategic risk…
Read the full takeSince the last report: The app remains in a maintenance state with no new features, but the reporting now provides greater transparency regarding the monetization of core features and identifies emerging competitive and regulatory threats.
Bottom line
MeAgain provides essential utility for GLP-1 users, but its aggressive paywall and current instability threaten long-term retention. The PM should prioritize stability and free-tier accessibility to build a sustainable user base before scaling monetization.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated